[9] Furthermore, depletion of FAP-expressing fibroblasts in serum transferred arthritis models reduced disease severity.[4] Importantly, FAP gene knockout mice develop normally and have no clinical disease phenotype, suggesting that targeting FAP will be less likely to cause fatal adverse effects.[10]. This evidence concerns the gene FAP and arthritic joint disease.